ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Multi-Scale Mapping of Gene Expression from Whole-slide Images for Identifying Phenotype-Associated Subpopulations.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Discovery of phenotype-associated subpopulations is critical for targeted therapies and prognostic biomarker discovery, which requires multi-scale gene expression. Deep learning advancements have enabled cost-effective genetic alteration inference from whole-slide images (WSIs), but most methods operate at a single scale. This study presents BiSCALE, a deep-learning framework that predicts gene expression from WSIs at both tissue (bulk) and near-cellular (spot) levels and links these predictions to clinical phenotypes. The framework integrates a WSI foundation encoder with a Vision-Mamba fusion module and a two-stage training strategy to bridge scale and distribution differences between bulk and spot data. Trained on 2109 bulk tumor samples and 141 000 spatial transcriptomics spots across three cancer types, BiSCALE outperforms established bulk and spatial baselines, generalizes well to independent cohorts, and demonstrates strong concordance between predicted bulk and spot expression profiles. It recovers biologically relevant pathway activity and supports downstream applications, including patient-level risk stratification from bulk WSIs and spot-level cell-identity annotation. BiSCALE also identifies phenotype-associated subpopulations, including niches linked to recurrence and hypoxia. These results establish BiSCALE as a cost-effective approach for multi-scale gene analysis and phenotype-associated feature discovery from routine pathology. All code used in this study are available at: https://github.com/Hailong-Zheng/BiSCALE.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.